Financial and clinical impact of team-based treatment for medicaid enrollees with diabetes in a federally qualified health center

Diabetes Care

Volumn 31, Issue 11, 2008, Pages 2160-2165

  Scanlon, Dennis P ^a   Hollenbeak, Christopher S ^b   Beich, Jeff ^a   Dyer, Anne Marie ^b   Gabbay, Robert A ^b   Milstein, Arnold ^c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c Mercer Health Benefits LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; HEALTH CARE COST; HEALTH CENTER; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; OUTCOME ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ECONOMICS; INSURANCE; PATIENT CARE; STATISTICS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

DIABETES MELLITUS; HUMANS; INSURANCE CLAIM REVIEW; MEDICAID; PATIENT CARE TEAM; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 59249097385     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0587     Document Type: Article

References (27)

1. Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academy Press, 2001
2. Anderson G, Horvath J: The growing burden of chronic disease in America. Public Health Rep 119:263-270, 2004
3. American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596-615, 2008
4. McGlynn EA, Asch SM, AdamsJ, KeeseyJ, Hicks J, DeCristofaro A, Kerr A: The quality of health care delivered to adults in the United States. N Engl J Med 348:2635-2645, 2003
5. Wagner EH, Austin BT, Davis C, Hind- marsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 20:64-78, 2001
6. Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S: Evidence-based disease management. JAMA 278:1687-1692, 1997
7. Leeman J, Mark B: The chronic care model versus disease management programs: a transaction cost analysis approach. Health Care Manage Rev 31:18 -25, 2006
8. Knight K, Badamgarav E, Henning JM, Hasselblad V, Anacleto AD, Ofman JJ, Weingarten SR: A systematic review of diabetes disease management programs. Am J Manag Care 11:242-250, 2005
9. Ofman JJ, Badamgarav E, Henning JM, Knight K, Levan R, Gur-Arie S, Richards M, Hasselblad V, Weingarten S: Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 117:182-192, 2004
10. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, Owens DK: Effects ofquality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 296:427-440, 2006
11. Villagra V: Strategies to control costs and quality: a focus on outcomes research for disease management. Med Care 42:III24-III30, 2004
12. An analysis of the literature on disease management programs [article online], Congressional Budget Office, 2004. Available from http://www.cbo.gov/ showdoc. cfm?index=5909&sequence = 0. Accessed 8 January 2007
13. Fireman B, Bartlett J, Selby J: Can disease management reduce health care costs by improving quality? Health Aff23:63-75, 2004
14. Gilmer TP, Philis-Tsimikas A, Walker C: Outcomes of Project Dulce: a culturally specific diabetes management program. Ann Pharmacother 39:817-822, 2005
15. Villagra V, Ahmed T: Effectiveness of a disease management program for patients with diabetes. Health Aff 23:255-266, 2004
16. Brown R, Peikes D, Chen A, Ng J, Schore J, Soh C: The Evaluation of the Medicare Coordinated Care Demonstration Project: Findings for the First Two Years. Princeton, NJ, Mathematica Policy Research, Inc., Document No. PR07-08, 2007
17. Landon BE, Hicks LS, O'Malley AJ, Lieu TA, Keegan T, McNeil BJ, Guadagnoli E: Improving the management of chronic diseases at community health centers. N Engl J Med 356:921-934, 2007
18. Institute for Healthcare Improvement: Home page, 2006. Available from http://www.ihi.org/ihi/about. Accessed 7 May 2006
19. Improving Chronic Illness Care: Home page, 2006. Available from http://www. improvingchroniccare.org/index.html. Accessed 7 May 2006
20. Wagner EH: The role of patient care teams in chronic disease management. Br Med J 320:569-572, 2000
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383, 1987
22. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
23. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55, 1983
24. Mullahy J: Interaction effects and differ- ence-in-difference estimation in loglinear models [article online], 1999. National Bureau of Economic Research Technical Working Paper Series No. 245. Available from http://www.nber.org/ papers/t0245. Accessed 19 May 2008
25. Chodosh J, Morton SC, Mojica W, Magli- one M, Suttorp MJ, Hilton L, Rhodes S, Shekelle P: Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med 143:427-438, 2005
26. Selby JV, Scanlon DP, Lafata JE, Villagra V, Beich J, Salber PR: Determining the value of disease management programs. Jt Comm J Qual Saf 29:491-499, 2003
27. Wagner EH, Sandhu N, Newton KM, Mc- Culloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA 285:182-189, 2001